Eli Lilly and Company announced the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to evaluate the efficacy and safety of baricitinib, an oral JAK1/JAK2 inhibitor. Read more...
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end of 2020. Read more...
MBio Diagnostics announced delivery to the DOD with funding for this effort provided by the Defense Health Program through the Joint Program Executive Office as part of a development program for a rapid, quantitative point-of-care test for the inflammatory protein IL-6. Read more...
Arch Biopartners announced the FDA has received and acknowledged the IND Application for its lead drug Metablok. Read more...